DINAMIQS is a CDMO specializing in end-to-end solutions for AAV and LVV manufacturing. Located in the Schlieren-Zurich Bio-Technopark, Switzerland, DINAMIQS offers comprehensive services, including genome and capsid optimization, process development, analytical characterization, and cGMP manufacturing to support the development and commercialization of gene therapy products. The company emphasizes streamlined scale-up processes and robust analytics strategies to ensure high-quality, reproducible results. In 2023, DINAMIQS became part of the Siegfried group, further enhancing its capabilities in the cell and gene therapy space.